Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
2801
DELISTED
Radius Health, Inc.
RDUS
| $2.75M | ﹤0.01% |
150,923
-32,637
| -18% | -$649K |
|
2802
Turning Point Brands
TPB
$1.75B
| $2.75M | ﹤0.01% |
60,075
+2,941
| +5% | +$136K |
|
2803
State Street SPDR ICE Preferred Securities ETF
PSK
$683M
| $2.74M | ﹤0.01% |
+62,010
| New | +$2.71M |
|
2804
Rhythm Pharmaceuticals
RYTM
$7.95B
| $2.74M | ﹤0.01% |
140,032
+3,878
| +3% | +$80.5K |
|
2805
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $2.74M | ﹤0.01% |
440,681
-2,276
| -0.5% | -$13.5K |
|
2806
Ducommun
DCO
$3.13B
| $2.72M | ﹤0.01% |
49,774
-448
| -0.9% | -$25.5K |
|
|
KRON
2807
DELISTED
Kronos Bio
KRON
| $2.71M | ﹤0.01% |
113,355
+74,750
| +194% | +$1.89M |
|
2808
PureCycle Technologies
PCT
$1.4B
| $2.71M | ﹤0.01% |
+114,572
| New | +$2.47M |
|
|
ETWO
2809
DELISTED
E2open Parent Holdings
ETWO
| $2.7M | ﹤0.01% |
236,362
+188,254
| +391% | +$2.17M |
|
2810
Lifecore Biomedical
LFCR
$179M
| $2.69M | ﹤0.01% |
239,514
+14,170
| +6% | +$163K |
|
2811
CarParts.com
PRTS
$47.1M
| $2.69M | ﹤0.01% |
13,231
+603
| +5% | +$101K |
|
2812
Banco Bradesco
BBD
$34.2B
| $2.69M | ﹤0.01% |
575,985
+143,878
| +33% | +$625K |
|
2813
Donegal Group Class A
DGICA
$696M
| $2.69M | ﹤0.01% |
184,420
-711
| -0.4% | -$10.9K |
|
2814
iShares Morningstar Growth ETF
ILCG
$3.29B
| $2.68M | ﹤0.01% |
41,435
-230
| -0.6% | -$14.1K |
|
2815
Recursion Pharmaceuticals
RXRX
$1.69B
| $2.68M | ﹤0.01% |
+73,394
| New | +$2.17M |
|
2816
Northrim BanCorp
NRIM
$606M
| $2.67M | ﹤0.01% |
249,904
-2,980
| -1% | -$32.4K |
|
|
MOFG
2817
DELISTED
MidWestOne Financial Group
MOFG
| $2.67M | ﹤0.01% |
92,754
-5,234
| -5% | -$161K |
|
2818
Vaxcyte
PCVX
$8.64B
| $2.67M | ﹤0.01% |
118,506
+33,669
| +40% | +$689K |
|
|
PTVE
2819
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $2.67M | ﹤0.01% |
176,957
+35,976
| +26% | +$540K |
|
2820
Bar Harbor Bankshares
BHB
$681M
| $2.66M | ﹤0.01% |
92,888
-4,751
| -5% | -$140K |
|
2821
MeiraGTx Holdings
MGTX
$1.25B
| $2.66M | ﹤0.01% |
171,567
+17,086
| +11% | +$244K |
|
2822
Sixth Street Specialty
TSLX
$1.78B
| $2.66M | ﹤0.01% |
119,782
+2,088
| +2% | +$46.2K |
|
|
CIO
2823
DELISTED
City Office REIT
CIO
| $2.65M | ﹤0.01% |
213,060
+4,041
| +2% | +$46.8K |
|
2824
Century Casinos
CNTY
$36M
| $2.64M | ﹤0.01% |
196,891
-19,018
| -9% | -$248K |
|
2825
OneWater Marine
ONEW
$198M
| $2.63M | ﹤0.01% |
62,675
-1,462
| -2% | -$67.9K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.